Ubs Group Ag Haleon PLC Call Options Transaction History
Ubs Group Ag
- $528 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding HLN
# of Institutions
683Shares Held
475MCall Options Held
166KPut Options Held
27.2K-
Dodge & Cox San Francisco, CA169MShares$1.61 Billion1.06% of portfolio
-
Clearbridge Investments, LLC New York, NY32.6MShares$311 Million0.3% of portfolio
-
Harding Loevner LP Bridgewater, NJ23.1MShares$220 Million1.89% of portfolio
-
Wellington Management Group LLP Boston, MA18.7MShares$178 Million0.04% of portfolio
-
Sculptor Capital LP New York, NY10.8MShares$104 Million4.86% of portfolio
About Haleon plc
- Ticker HLN
- Exchange
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 4,617,290,240
- Market Cap $44B
- Description
- Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...